# Integrative Bioinformatics-Guided Analysis of Glomerular Transcriptome Implicates Potential Therapeutic Targets and Pathogenesis Mechanisms in IgA Nephropathy

**Authors:** Tiange Yang, Mengde Dai, Fen Zhang, Weijie Wen

PMC · DOI: 10.3390/bioengineering12101040 · Bioengineering · 2025-09-27

## TL;DR

This study identifies key genes and immune pathways involved in IgA nephropathy, a kidney disease, and suggests potential targets for new diagnostics and treatments.

## Contribution

The study introduces four novel hub genes with high diagnostic accuracy and links them to immune-related pathways in IgA nephropathy.

## Key findings

- 165 differentially expressed genes were identified in IgA nephropathy, including four hub genes (FOSB, SLC19A2, PER1, SOX17).
- Hub genes are associated with immune pathways like IL-17 signaling and complement activation.
- The hub genes showed high diagnostic accuracy with AUC values ranging from 0.956 to 0.995.

## Abstract

(1) Background: IgA nephropathy (IgAN) is a leading cause of chronic kidney disease worldwide. Despite its prevalence, the molecular mechanisms of IgAN remain poorly understood, partly due to limited research scale. Identifying key genes involved in IgAN’s pathogenesis is critical for novel diagnostic and therapeutic strategies. (2) Methods: We identified differentially expressed genes (DEGs) by analyzing public datasets from the Gene Expression Omnibus. Gene Ontology and Kyoto Encyclopedia of Genes and Genomes analyses were performed to elucidate the biological roles of DEGs. Hub genes were screened using weighted gene co-expression network analysis combined with machine learning algorithms. Immune infiltration analysis was conducted to explore associations between hub genes and immune cell profiles. The hub genes were validated using receiver operating characteristic curves and area under the curve. (3) Results: We identified 165 DEGs associated with IgAN and revealed pathways such as IL-17 signaling and complement and coagulation cascades, and biological processes including response to xenobiotic stimuli. Four hub genes were screened: three downregulated (FOSB, SLC19A2, PER1) and one upregulated (SOX17). The AUC values for identifying IgAN in the training and testing set ranged from 0.956 to 0.995. Immune infiltration analysis indicated that hub gene expression correlated with immune cell abundance, suggesting their involvement in IgAN’s immune pathogenesis. (4) Conclusion: This study identifies FOSB, SLC19A2, PER1, and SOX17 as novel hub genes with high diagnostic accuracy for IgAN. These genes, linked to immune-related pathways such as IL-17 signaling and complement activation, offer promising targets for diagnostic development and therapeutic intervention, enhancing our understanding of IgAN’s molecular and immune mechanisms.

## Linked entities

- **Genes:** FOSB (FosB proto-oncogene, AP-1 transcription factor subunit) [NCBI Gene 2354], SLC19A2 (solute carrier family 19 member 2) [NCBI Gene 10560], PER1 (period circadian regulator 1) [NCBI Gene 5187], SOX17 (SRY-box transcription factor 17) [NCBI Gene 64321]
- **Diseases:** IgA nephropathy (MONDO:0005342), chronic kidney disease (MONDO:0005300)

## Full-text entities

- **Genes:** IL17A (interleukin 17A) [NCBI Gene 3605] {aka CTLA-8, CTLA8, IL-17, IL-17A, IL17, ILA17}, PER1 (period circadian regulator 1) [NCBI Gene 5187] {aka PER, RIGUI, hPER}, FOSB (FosB proto-oncogene, AP-1 transcription factor subunit) [NCBI Gene 2354] {aka AP-1, G0S3, GOS3, GOSB}, SLC19A2 (solute carrier family 19 member 2) [NCBI Gene 10560] {aka TC1, THMD1, THT1, THTR1, TRMA}, SOX17 (SRY-box transcription factor 17) [NCBI Gene 64321] {aka PPH7, VUR3}
- **Diseases:** IgA Nephropathy (MESH:D005922), chronic kidney disease (MESH:D051436)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12561849/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12561849/full.md

## References

56 references — full list in the complete paper: https://tomesphere.com/paper/PMC12561849/full.md

---
Source: https://tomesphere.com/paper/PMC12561849